Symptomatic response to imatinib mesylate in cutaneous mastocytosis associated with chronic myelomonocytic leukemia

Por Vannorsdall, E.J., Collins, J.A., Chen, Q.C., Sarai, G., Baer, M.R.
Publicado em 2013

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

Por Baer, MR, George, SL, Sanford, BL, Mrózek, K, Kolitz, JE, Moore, JO, Stone, RM, Powell, BL, Caligiuri, MA, Bloomfield, CD, Larson, RA
Publicado em 2011

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

Por Whitman, SP, Caligiuri, MA, Maharry, K, Radmacher, MD, Kohlschmidt, J, Becker, H, Mrózek, K, Wu, Y-Z, Schwind, S, Metzeler, KH, Mendler, JH, Wen, J, Baer, MR, Powell, BL, Carter, TH, Kolitz, JE, Wetzler, M, Carroll, AJ, Larson, RA, Marcucci, G, Bloomfield, CD
Publicado em 2012

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid...

Por Metzeler, KH, Maharry, K, Kohlschmidt, J, Volinia, S, Mrózek, K, Becker, H, Nicolet, D, Whitman, SP, Mendler, JH, Schwind, S, Eisfeld, A-K, Wu, Y-Z, Powell, BL, Carter, TH, Wetzler, M, Kolitz, JE, Baer, MR, Carroll, AJ, Stone, RM, Caligiuri, MA, Marcucci, G, Bloomfield, CD
Publicado em 2013

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

Por Kayser, S, Krzykalla, J, Elliott, MA, Norsworthy, K, Gonzales, P, Hills, RK, Baer, MR, Ráčil, Z, Mayer, J, Novak, J, Žák, P, Szotkowski, T, Grimwade, D, Russell, NH, Walter, RB, Estey, EH, Westermann, J, Görner, M, Benner, A, Krämer, A, Smith, BD, Burnett, AK, Thiede, C, Röllig, C, Ho, AD, Ehninger, G, Schlenk, RF, Tallman, MS, Levis, MJ, Platzbecker, U
Publicado no Leukemia (2017)